TSXV - Delayed Quote CAD

NeuPath Health Inc. (NPTH.V)

0.1950

+0.0050

+(2.63%)

At close: April 25 at 3:34:16 PM EDT

NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH

TORONTO, April 15, 2025--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, is pleased to announce the appointment of Stephen Lemieux, CPA, in the newly created role of President, effective May 1, 2025. Mr. Lemieux brings more than 20 years of executive experience in the healthcare and biopharmaceutical sectors, with a successful track record in operations, financial strategy and M&A execut

Business Wire 10 days ago

NPTH.NE

NPTH.V
+2.63%
NeuPath Health Full Year 2024 Earnings: CA$0.013 loss per share (vs CA$0.002 loss in FY 2023)

NeuPath Health ( CVE:NPTH ) Full Year 2024 Results Key Financial Results Revenue: CA$72.8m (up 10% from FY 2023). Net...

Simply Wall St. 27 days ago

NPTH.NE

NPTH.V
+2.63%
NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2024 RESULTS

TORONTO, March 27, 2025--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months and year ended December 31, 2024. All figures are in Canadian dollars, unless otherwise noted.

Business Wire 29 days ago

NPTH.NE

NPTH.V
+2.63%
NEUPATH HEALTH SECURES NEW CREDIT FACILITIES TO DRIVE GROWTH AND TO REFINANCE EXISTING DEBT

TORONTO, March 27, 2025--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that it has entered into a new credit agreement (the "Credit Agreement") with the National Bank of Canada ("National Bank"), providing an aggregate of up to $13.5 million, comprising of a (i) $4.0 million revolving credit facility (the "Revolving Facility"), (ii) $3.0 million non-revolving delayed dr

Business Wire 29 days ago

NPTH.NE

NPTH.V
+2.63%
NEUPATH HEALTH THE FIRST NORTH AMERICAN PROVIDER OF ARTHROSAMID®, A REVOLUTIONARY INJECTION FOR KNEE OSTEOARTHRITIS

TORONTO, March 06, 2025--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that it has performed the first-ever injection of Arthrosamid in North America at its Mississauga, Ontario clinic. Prior to Health Canada’s approval of Arthrosamid, patients would travel to Europe to access this innovative hydrogel that has been shown to provide up to four years of pain relief for kn

Business Wire last month

NPTH.NE

NPTH.V
+2.63%
NEUPATH HEALTH ANNOUNCES ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS

TORONTO, December 10, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the grant of stock options ("Options") and restricted share units ("RSUs"). All figures are in Canadian dollars, unless otherwise noted.

Business Wire 4 months ago

NPTH.V
+2.63%
NEUPATH HEALTH ANNOUNCES APPROVAL OF NORMAL COURSE ISSUER BID

TORONTO, November 27, 2024--NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the "Company") announced today that the TSX Venture Exchange (the "Exchange") has accepted a notice filed by NeuPath of its intention to make a Normal Course Issuer Bid ("NCIB") to be transacted through the facilities of the Exchange.

Business Wire 4 months ago

NPTH.V
+2.63%
NeuPath Health Third Quarter 2024 Earnings: CA$0.007 loss per share (vs CA$0.007 profit in 3Q 2023)

NeuPath Health ( CVE:NPTH ) Third Quarter 2024 Results Key Financial Results Revenue: CA$17.6m (up 9.1% from 3Q 2023...

Simply Wall St. 5 months ago

NPTH.V
+2.63%
NEUPATH HEALTH REPORTS THIRD QUARTER 2024 RESULTS

TORONTO, November 14, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and nine months ended September 30, 2024. All figures are in Canadian dollars, unless otherwise noted.

Business Wire 5 months ago

NPTH.V
+2.63%
NEUPATH HEALTH TO BE FEATURED ON RADIUS RESEARCH’S PITCH, DEEP DIVE AND Q&A WEBINAR

TORONTO, October 21, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), is pleased to invite investors and other interested parties to attend an upcoming interview with Market Radius Research.

Business Wire 6 months ago

NPTH.V
+2.63%
NeuPath Health Second Quarter 2024 Earnings: EPS: CA$0.005 (vs CA$0.001 in 2Q 2023)

NeuPath Health ( CVE:NPTH ) Second Quarter 2024 Results Key Financial Results Revenue: CA$18.9m (up 10% from 2Q 2023...

Simply Wall St. 8 months ago

NPTH.V
+2.63%
NEUPATH HEALTH REPORTS SECOND QUARTER 2024 RESULTS

TORONTO, August 15, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and six months ended June 30, 2024. All figures are in Canadian dollars, unless otherwise noted.

Business Wire 8 months ago

NPTH.V
+2.63%
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

TORONTO, June 13, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held on June 12, 2024. All figures are in Canadian dollars, unless otherwise noted.

Business Wire 10 months ago

NPTH.V
+2.63%
NEUPATH HEALTH REPORTS RECORD QUARTERLY REVENUES WITH FIRST QUARTER 2024 RESULTS

TORONTO, May 16, 2024--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three months ended March 31, 2024. All figures are in Canadian dollars, unless otherwise noted.

Business Wire 11 months ago

NPTH.V
+2.63%

Performance Overview

Return	NPTH.V	S&P/TSX Composite index (^GSPTSE)
YTD	-2.50%	+0.37%
1-Year	+14.71%	+12.91%
3-Year	-65.79%	+17.60%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

NeuPath Health Inc. (NPTH.V)

NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH

NeuPath Health Full Year 2024 Earnings: CA$0.013 loss per share (vs CA$0.002 loss in FY 2023)

NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2024 RESULTS

NEUPATH HEALTH SECURES NEW CREDIT FACILITIES TO DRIVE GROWTH AND TO REFINANCE EXISTING DEBT

NEUPATH HEALTH THE FIRST NORTH AMERICAN PROVIDER OF ARTHROSAMID®, A REVOLUTIONARY INJECTION FOR KNEE OSTEOARTHRITIS

NEUPATH HEALTH ANNOUNCES ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS

NEUPATH HEALTH ANNOUNCES APPROVAL OF NORMAL COURSE ISSUER BID

NeuPath Health Third Quarter 2024 Earnings: CA$0.007 loss per share (vs CA$0.007 profit in 3Q 2023)

NEUPATH HEALTH REPORTS THIRD QUARTER 2024 RESULTS

NEUPATH HEALTH TO BE FEATURED ON RADIUS RESEARCH’S PITCH, DEEP DIVE AND Q&A WEBINAR

NeuPath Health Second Quarter 2024 Earnings: EPS: CA$0.005 (vs CA$0.001 in 2Q 2023)

NEUPATH HEALTH REPORTS SECOND QUARTER 2024 RESULTS

NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

NEUPATH HEALTH REPORTS RECORD QUARTERLY REVENUES WITH FIRST QUARTER 2024 RESULTS

Performance Overview